LoginRegister
    Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from USAurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US
    Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nodSarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod
    Cipla associate Avenue Therapeutics files US application for IV tramadolCipla associate Avenue Therapeutics files US application for IV tramadol
    Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn MZydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M
    Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding productionMumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production
    Sanofi, Regeneron to restructure antibody collaboration for Kevzara, PraluentSanofi, Regeneron to restructure antibody collaboration for Kevzara, Praluent
    AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readoutAstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout
    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a dayEdelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day
    CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive databaseCDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database
    Subscription of Piramal debentures by Canadian investor approved by CCISubscription of Piramal debentures by Canadian investor approved by CCI
    Merck to acquire cancer drug developer ArQule for USD 2.7 billionMerck to acquire cancer drug developer ArQule for USD 2.7 billion
    Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEOTransasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X